Intellectual property and assisted reproductive technology
By David Cyranoski, Jorge L. Contreras & Victoria T. Carrington,
Nature Biotechnology
| 01. 18. 2023
Stanford bioethicist Henry Greely predicts that a large proportion of human pregnancies — perhaps even 90% in the United States — will one day result from in vitro gametogenesis (IVG), the production of eggs and sperm from undifferentiated human cells1. Whether or not this prediction proves accurate, it is likely that IVG will fundamentally change how humans reproduce. IVG could offer the possibility of reproduction to those experiencing infertility, allow parents to choose from hundreds of genetically characterized embryos, enable relatively safe germline genetic modification, and open the door for same-sex parents to have genetically related offspring. Some assisted reproduction experts, like Jacques Cohen of the ART Institute of Washington, predict that IVG will replace virtually all conventional in vitro fertilization (IVF) procedures for those experiencing problems with fertility (J. Cohen, personal communication). Greely suspects that eventually most prospective parents — even those without fertility problems — will opt for IVG to reduce the risk of bearing offspring with genetic defects or to select for desirable traits.
It is not surprising, then, that researchers who are putting together...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...